BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2025 8:12:03 AM | Browse: 43 | Download: 95
 |
Received |
|
2024-08-19 21:02 |
|
Peer-Review Started |
|
2024-08-19 21:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-10-20 11:04 |
|
Revised |
|
2024-10-31 15:36 |
|
Second Decision |
|
2024-11-20 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-11-20 08:00 |
|
Articles in Press |
|
2024-11-20 08:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-11-25 14:35 |
|
Typeset the Manuscript |
|
2024-12-13 03:21 |
|
Publish the Manuscript Online |
|
2025-01-18 08:12 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Prognosis in stage II colon cancer: Expanding the horizons of risk factors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
María Belén Novoa Díaz, Claudia Gentili, María Julia Martín and Pedro Carriere |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Consejo Nacional de Investigaciones Científicas y Técnicas |
No. PIP11220200103061CO |
| Agencia Nacional de promoción Científica y Tecnológica |
No. PICT-2020-SERIEA-03440 |
| Universidad Nacional del Sur |
No. PGI 24/B303 |
| Universidad Nacional del Sur |
No. PGI 24/ZB01 |
|
| Corresponding Author |
María Julia Martín, PhD, Department of Biología, Bioquímica y Farmacia, Universidad Nacional del Sur (UNS)-INIBIBB(CONICET-UNS), Av La Carrindanga Km7, Bahía Blanca 8000, Buenos Aires, Argentina. julia.martin@uns.edu.ar |
| Key Words |
Risk factor; Prognosis; Colon cancer; Inflammation markers; Tumor location |
| Core Tip |
The treatment of patients with stage II colon cancer after surgical resection of the tumor is still under debate. Standard management based on the clinicopathological perspective is insufficient in cases not categorized as high-risk patients. Risk factors associated with the tumor and its microenvironment, including immune and inflammatory status, diet, and nutritional balance, should not be ruled out. The use of non-invasive molecular techniques to analyze these factors can provide relevant information in medical decisions for this group of patients. |
| Publish Date |
2025-01-18 08:12 |
| Citation |
<p>Novoa Díaz MB, Gentili C, Martín MJ, Carriere P. Prognosis in stage II colon cancer: Expanding the horizons of risk factors. <i>World J Gastrointest Oncol</i> 2025; 17(2): 100552</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i2/100552.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i2.100552 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
